Phase II trial of oral vinorelbine in combination with cisplatin in advanced non small cell lung cancer (NSCLC)

被引：0
|
作者：
Garassino, I [1 ]
Campagnoli, E. [1 ]
Cavina, R. [1 ]
Soto, Parra H. J. [1 ]
De Vincenzo, F. [1 ]
Zucali, P. A. [1 ]
Salamina, S. [1 ]
Ceresoli, G. L. [1 ]
Santoro, A. [1 ]
机构：
[1] Ist Clin Humanitas, Dept Med Oncol & Hematol, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI20 / XI20
页数：1
相关论文
共 50 条
  • [41] Gemcitabine-cisplatin-vinorelbine phase II trial in stage III non small cell lung cancer
    Cueva, JF
    Grande, C
    Firvida, J
    Amenedo, M
    Lázaro, M
    Romero, C
    Quintero, G
    Huidobro, G
    García, J
    Barón, FJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S259 - S259
  • [42] PHASE-II TRIAL OF ORAL IDARUBICIN IN ADVANCED NON-SMALL CELL LUNG-CANCER (NSCLC)
    ARDIZZONI, A
    PRONZATO, P
    REPETTO, L
    DEPALMA, M
    CANOBBIO, L
    GULISANO, M
    FUSCO, V
    ROSSO, R
    GANZINA, F
    CANCER INVESTIGATION, 1988, 6 (04) : 409 - 411
  • [43] PHASE 1 STUDY OF ORAL VINORELBINE IN COMBINATION WITH ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) USING A METRONOMIC SCHEDULE
    Chua, Clarinda
    Chowbay, Balram
    Tan, Eng-Huat
    Hui, Kam-Man
    Toh, Chee-Keong
    Leong, Swan-Swan
    Ang, Mei-Kim
    Ng, Raymond
    Hou, Xuan
    Lim, Wan-Teck
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1246 - S1247
  • [44] A phase II trial of oral UFT plus cisplatin (CDDP) in patients with non-small cell lung cancer (NSCLC)
    Saito, J
    Nakai, Y
    Saijo, Y
    Nukiwa, T
    Koinumaru, S
    Matsuura, Y
    Aso, N
    Yamane, Y
    Tsukamoto, T
    Sayama, T
    Nakabayashi, T
    LUNG CANCER, 2001, 31 (2-3) : 285 - 293
  • [45] A phase II trial of vinorelbine and cisplatin in previously untreated inoperable non-small-cell lung cancer
    Perng, RP
    Shih, JF
    Chen, YM
    Delgado, FM
    Tsai, CM
    Chou, KC
    Liu, JM
    Chern, MS
    Whang-Peng, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (01): : 60 - 64
  • [46] A phase II trial of weekly cisplatin and docetaxel in advanced non-small cell lung cancer (NSCLC)-Final report
    Sovak, M. A.
    Guensch, L.
    Joyce, P.
    Lutzker, S. G.
    Schwartz, S.
    Shih, W. J.
    Zheng, L.
    Aisner, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [47] PHASE II STUDY OF BEVACIZUMAB IN COMBINATION WITH CISPLATIN AND VINORELBINE AS FIRST LINE TREATMENT OF PATIENTS (PTS) WITH ADVANCED OR METASTATIC, NON SQUAMOUS, NON-SMALL-CELL LUNG CANCER (NSCLC)
    Leon, L.
    Gracia, J. M.
    Vazquez, S.
    Firvida, J. L.
    Amenedo, M.
    Casal, J.
    Gallego, R.
    Lazaro, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 121 - 121
  • [48] Phase II trial of mitoxantrone and cisplatin in advanced non-small-cell lung cancer
    Feun, LG
    Savaraj, N
    Solomon, J
    Liebmann, A
    Hurley, J
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (02): : 190 - 192
  • [49] A phase I pharmacokinetic study of bexarotene with vinorelbine and cisplatin in patients with advanced non-small-cell lung cancer (NSCLC)
    Heather A. Wakelee
    Gary Middleton
    David Dunlop
    Rodryg Ramlau
    Natasha Leighl
    Desiree Hao
    Arturo Lopez-Anaya
    Petr Zatloukal
    Charlotte D. Jacobs
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 815 - 824
  • [50] Phase III randomized trial of docetaxel in combination with cisplatin or carboplatin or vinorelbine plus cisplatin in advanced non-small cell lung cancer: Interim analysis
    Belani, C
    SEMINARS IN ONCOLOGY, 2001, 28 (03) : 10 - 14
12345